NCT00332319View on ClinicalTrials.gov

Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients

PHASE2TerminatedINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions

Incontinence, Urinary and Urinary Bladder, OveractiveOveractive Bladder

Interventions

DRUG

GW679769

Trial Locations (3)

19107

GSK Investigational Site, Philadelphia

44195

GSK Investigational Site, Cleveland

90806

GSK Investigational Site, Long Beach

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY